English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Tuesday, April 16, 2024
NEC、SBTiからNet-Zero目標の認定を取得
Thursday, April 11, 2024
DOCOMO, NTT, NEC and Fujitsu Develop Top-level Sub-terahertz 6G Device Capable of Ultra-high-speed 100 Gbps Transmission
Wednesday, April 10, 2024
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024
Monday, April 8, 2024
NEC white paper proposes comprehensive process workflow for the application of AI-driven personalized cancer vaccines
Monday, March 25, 2024
NEC develops marketing strategy planning & effectiveness simulation technology using generative AI
Friday, March 22, 2024
NEC and NTT successfully conduct first-of-its-kind long-distance transmission experiment over 7,000km using 12-core optical fiber
Thursday, March 21, 2024
NEC and Tokyo Medical and Dental University use AI to assist self-care for chronic lower back pain
Wednesday, March 20, 2024
NEC and Skyloom to Pioneer 100 Gbps Space Optical Communications, Transforming Global Internet Connectivity
Thursday, March 7, 2024
NEC named to list of Top 100 Global Innovators by Clarivate for 13th consecutive year
Tuesday, March 5, 2024
Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050
NEC Corporation Links

https://www.facebook.com/nec.global/

https://twitter.com/NEC_corp

https://www.youtube.com/user/NECglobalOfficial

https://www.linkedin.com/company/nec/

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575